|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 492 for Il33

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.087s

Categories

Category: Publication
Type Details Score
Publication
First Author: Shani O
Year: 2020
Journal: Cancer Res
Title: Fibroblast-Derived IL33 Facilitates Breast Cancer Metastasis by Modifying the Immune Microenvironment and Driving Type 2 Immunity.
Volume: 80
Issue: 23
Pages: 5317-5329
Publication
First Author: Shan B
Year: 2021
Journal: Genes Dev
Title: Cold-responsive adipocyte progenitors couple adrenergic signaling to immune cell activation to promote beige adipocyte accrual.
Volume: 35
Issue: 19-20
Pages: 1333-1338
Publication
First Author: Ring SS
Year: 2021
Journal: Nat Commun
Title: Viral vector-mediated reprogramming of the fibroblastic tumor stroma sustains curative melanoma treatment.
Volume: 12
Issue: 1
Pages: 4734
Publication
First Author: Talabot-Ayer D
Year: 2015
Journal: J Immunol
Title: Severe neutrophil-dominated inflammation and enhanced myelopoiesis in IL-33-overexpressing CMV/IL33 mice.
Volume: 194
Issue: 2
Pages: 750-60
Publication
First Author: Guo XJ
Year: 2018
Journal: Immunity
Title: Lung γδ T Cells Mediate Protective Responses during Neonatal Influenza Infection that Are Associated with Type 2 Immunity.
Volume: 49
Issue: 3
Pages: 531-544.e6
Publication      
First Author: Wu J
Year: 2024
Journal: Biol Reprod
Title: Activation of Interleukin33-NFκB Axis in granulosa cells during atresia and its role in disposal of Atretic follicles.
Publication
First Author: Lefrançais E
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells.
Volume: 111
Issue: 43
Pages: 15502-7
Publication
First Author: Wu J
Year: 2015
Journal: J Immunol
Title: IL-33 is required for disposal of unnecessary cells during ovarian atresia through regulation of autophagy and macrophage migration.
Volume: 194
Issue: 5
Pages: 2140-7
Publication
First Author: Carlock C
Year: 2017
Journal: Transl Psychiatry
Title: Interleukin33 deficiency causes tau abnormality and neurodegeneration with Alzheimer-like symptoms in aged mice.
Volume: 7
Issue: 7
Pages: e1164
Publication
First Author: Zhang Y
Year: 2017
Journal: Mol Carcinog
Title: IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis.
Volume: 56
Issue: 1
Pages: 272-287
Publication  
First Author: He Z
Year: 2018
Journal: Cytokine
Title: Interleukin 33 regulates gene expression in intestinal epithelial cells independently of its nuclear localization.
Volume: 111
Pages: 146-153
Publication
First Author: Eissmann MF
Year: 2018
Journal: Cancer Immunol Res
Title: Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ-Dependent Manner.
Volume: 6
Issue: 4
Pages: 409-421
Publication
First Author: Chen WY
Year: 2015
Journal: Proc Natl Acad Sci U S A
Title: Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33.
Volume: 112
Issue: 23
Pages: 7249-54
Publication
First Author: Brusilovsky M
Year: 2021
Journal: Nat Immunol
Title: Environmental allergens trigger type 2 inflammation through ripoptosome activation.
Volume: 22
Issue: 10
Pages: 1316-1326
Publication
First Author: Chen WY
Year: 2018
Journal: Exp Mol Med
Title: IL-33/ST2 axis mediates hyperplasia of intrarenal urothelium in obstructive renal injury.
Volume: 50
Issue: 4
Pages: 36
Publication
First Author: Chen WY
Year: 2016
Journal: Biochem Biophys Res Commun
Title: Upregulation of Interleukin-33 in obstructive renal injury.
Volume: 473
Issue: 4
Pages: 1026-1032
Publication
First Author: He D
Year: 2022
Journal: Immunity
Title: Disruption of the IL-33-ST2-AKT signaling axis impairs neurodevelopment by inhibiting microglial metabolic adaptation and phagocytic function.
Volume: 55
Issue: 1
Pages: 159-173.e9
Publication
First Author: Hatzioannou A
Year: 2020
Journal: Nat Immunol
Title: An intrinsic role of IL-33 in Treg cell-mediated tumor immunoevasion.
Volume: 21
Issue: 1
Pages: 75-85
Publication
First Author: Du J
Year: 2023
Journal: Cell Death Dis
Title: PTRF-IL33-ZBP1 signaling mediating macrophage necroptosis contributes to HDM-induced airway inflammation.
Volume: 14
Issue: 7
Pages: 432
Publication  
First Author: Burganova G
Year: 2023
Journal: Front Endocrinol (Lausanne)
Title: Pericytes modulate islet immune cells and insulin secretion through Interleukin-33 production in mice.
Volume: 14
Pages: 1142988
Publication
First Author: Xiao Y
Year: 2019
Journal: Cell Mol Gastroenterol Hepatol
Title: Interleukin-33 Promotes REG3γ Expression in Intestinal Epithelial Cells and Regulates Gut Microbiota.
Volume: 8
Issue: 1
Pages: 21-36
Publication
First Author: Byers DE
Year: 2013
Journal: J Clin Invest
Title: Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease.
Volume: 123
Issue: 9
Pages: 3967-82
Publication
First Author: Stier MT
Year: 2019
Journal: J Immunol
Title: IL-33 Is a Cell-Intrinsic Regulator of Fitness during Early B Cell Development.
Volume: 203
Issue: 6
Pages: 1457-1467
Publication
First Author: Strangward P
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: Targeting the IL33-NLRP3 axis improves therapy for experimental cerebral malaria.
Volume: 115
Issue: 28
Pages: 7404-7409
Publication
First Author: Waddell A
Year: 2021
Journal: Sci Rep
Title: IL-33 is produced by colon fibroblasts and differentially regulated in acute and chronic murine colitis.
Volume: 11
Issue: 1
Pages: 9575
Publication      
First Author: Wu J
Year: 2021
Journal: Mol Psychiatry
Title: Requirement of brain interleukin33 for aquaporin4 expression in astrocytes and glymphatic drainage of abnormal tau.
Publication  
First Author: Kato T
Year: 2019
Journal: Front Immunol
Title: Interleukin-1/-33 Signaling Pathways as Therapeutic Targets for Endometriosis.
Volume: 10
Pages: 2021
Publication
First Author: Wu K
Year: 2020
Journal: J Immunol
Title: Group 2 Innate Lymphoid Cells Must Partner with the Myeloid-Macrophage Lineage for Long-Term Postviral Lung Disease.
Volume: 205
Issue: 4
Pages: 1084-1101
Publication
First Author: Adachi T
Year: 2020
Journal: Int Immunol
Title: Lung fibroblasts produce IL-33 in response to stimulation with retinoblastoma-binding protein 9 via production of prostaglandin E2.
Volume: 32
Issue: 10
Pages: 637-652
Publication
First Author: Cosway EJ
Year: 2023
Journal: Nat Commun
Title: The alarmin IL33 orchestrates type 2 immune-mediated control of thymus regeneration.
Volume: 14
Issue: 1
Pages: 7201
Publication
First Author: Aneas I
Year: 2021
Journal: Nat Commun
Title: Asthma-associated genetic variants induce IL33 differential expression through an enhancer-blocking regulatory region.
Volume: 12
Issue: 1
Pages: 6115
Publication
First Author: Fang M
Year: 2017
Journal: Cancer Res
Title: IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment.
Volume: 77
Issue: 10
Pages: 2735-2745
Publication  
First Author: Yasuoka S
Year: 2011
Journal: Brain Res
Title: Production and functions of IL-33 in the central nervous system.
Volume: 1385
Pages: 8-17
Publication
First Author: Lefrançais E
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G.
Volume: 109
Issue: 5
Pages: 1673-8
Publication
First Author: DaSilva-Arnold SC
Year: 2018
Journal: Arch Dermatol Res
Title: Phenotyping acute and chronic atopic dermatitis-like lesions in Stat6VT mice identifies a role for IL-33 in disease pathogenesis.
Volume: 310
Issue: 3
Pages: 197-207
Publication
First Author: Toki S
Year: 2018
Journal: J Allergy Clin Immunol
Title: Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo.
Volume: 142
Issue: 5
Pages: 1515-1528.e8
Publication
First Author: Gao K
Year: 2013
Journal: Cancer Lett
Title: Transgenic expression of IL-33 activates CD8(+) T cells and NK cells and inhibits tumor growth and metastasis in mice.
Volume: 335
Issue: 2
Pages: 463-71
Publication
First Author: Bruhs A
Year: 2018
Journal: J Invest Dermatol
Title: Disruption of the Epidermal Barrier Induces Regulatory T Cells via IL-33 in Mice.
Volume: 138
Issue: 3
Pages: 570-579
Publication
First Author: Imai Y
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice.
Volume: 110
Issue: 34
Pages: 13921-6
Publication
First Author: Imai Y
Year: 2017
Journal: Sci Rep
Title: Expression of IL-33 in ocular surface epithelium induces atopic keratoconjunctivitis with activation of group 2 innate lymphoid cells in mice.
Volume: 7
Issue: 1
Pages: 10053
Publication
First Author: Aparicio-Domingo P
Year: 2021
Journal: Eur J Immunol
Title: Fibroblast-derived IL-33 is dispensable for lymph node homeostasis but critical for CD8 T-cell responses to acute and chronic viral infection.
Volume: 51
Issue: 1
Pages: 76-90
Publication
First Author: Hung LY
Year: 2021
Journal: Am J Pathol
Title: Myeloid-Derived IL-33 Limits the Severity of Dextran Sulfate Sodium-Induced Colitis.
Volume: 191
Issue: 2
Pages: 266-273
Publication  
First Author: Rose WA 2nd
Year: 2015
Journal: Sci Rep
Title: IL-33 released by alum is responsible for early cytokine production and has adjuvant properties.
Volume: 5
Pages: 13146
Publication  
First Author: Steer CA
Year: 2020
Journal: JCI Insight
Title: Lung group 2 innate lymphoid cells are trained by endogenous IL-33 in the neonatal period.
Volume: 5
Issue: 14
Publication
First Author: Mathä L
Year: 2019
Journal: PLoS One
Title: Female and male mouse lung group 2 innate lymphoid cells differ in gene expression profiles and cytokine production.
Volume: 14
Issue: 3
Pages: e0214286
Publication  
First Author: Okragly AJ
Year: 2016
Journal: Cytokine
Title: Elevated levels of Interleukin (IL)-33 induce bone pathology but absence of IL-33 does not negatively impact normal bone homeostasis.
Volume: 79
Pages: 66-73
Publication
First Author: Vasseur P
Year: 2017
Journal: Oncotarget
Title: Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis.
Volume: 8
Issue: 30
Pages: 48563-48574
Publication
First Author: Athari SK
Year: 2016
Journal: Arthritis Res Ther
Title: Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33.
Volume: 18
Issue: 1
Pages: 143
Publication  
First Author: Robin A
Year: 2023
Journal: Front Immunol
Title: Early activation and recruitment of invariant natural killer T cells during liver ischemia-reperfusion: the major role of the alarmin interleukin-33.
Volume: 14
Pages: 1099529
Publication  
First Author: Carrière V
Year: 2017
Journal: Mediators Inflamm
Title: Endogenous IL-33 Deficiency Exacerbates Liver Injury and Increases Hepatic Influx of Neutrophils in Acute Murine Viral Hepatitis.
Volume: 2017
Pages: 1359064
Publication
First Author: Levescot A
Year: 2014
Journal: Cancer Res
Title: BCR-ABL-induced deregulation of the IL-33/ST2 pathway in CD34+ progenitors from chronic myeloid leukemia patients.
Volume: 74
Issue: 10
Pages: 2669-76
Publication
First Author: McLaren JE
Year: 2019
Journal: J Immunol
Title: IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine.
Volume: 202
Issue: 3
Pages: 943-955
Publication
First Author: Yong HM
Year: 2022
Journal: Allergy
Title: Epigenetic regulation of epithelial dectin-1 through an IL-33-STAT3 axis in allergic disease.
Volume: 77
Issue: 1
Pages: 207-217
Publication
First Author: Louten J
Year: 2011
Journal: Int Immunol
Title: Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation.
Volume: 23
Issue: 5
Pages: 307-15
Publication  
First Author: Dohi E
Year: 2017
Journal: eNeuro
Title: Behavioral Changes in Mice Lacking Interleukin-33.
Volume: 4
Issue: 6
Publication
First Author: Rak GD
Year: 2016
Journal: J Invest Dermatol
Title: IL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing.
Volume: 136
Issue: 2
Pages: 487-496
Publication
First Author: Sundnes O
Year: 2015
Journal: J Invest Dermatol
Title: Epidermal Expression and Regulation of Interleukin-33 during Homeostasis and Inflammation: Strong Species Differences.
Volume: 135
Issue: 7
Pages: 1771-1780
Publication
First Author: Haenuki Y
Year: 2012
Journal: J Allergy Clin Immunol
Title: A critical role of IL-33 in experimental allergic rhinitis.
Volume: 130
Issue: 1
Pages: 184-94.e11
Publication
First Author: Moran TP
Year: 2015
Journal: Am J Physiol Lung Cell Mol Physiol
Title: Inhaled house dust programs pulmonary dendritic cells to promote type 2 T-cell responses by an indirect mechanism.
Volume: 309
Issue: 10
Pages: L1208-18
Publication
First Author: Sung HY
Year: 2019
Journal: J Neurochem
Title: Down-regulation of interleukin-33 expression in oligodendrocyte precursor cells impairs oligodendrocyte lineage progression.
Volume: 150
Issue: 6
Pages: 691-708
Publication  
First Author: Luo Q
Year: 2018
Journal: Neuroscience
Title: Interleukin-33 Protects Ischemic Brain Injury by Regulating Specific Microglial Activities.
Volume: 385
Pages: 75-89
Publication
First Author: Augustine J
Year: 2019
Journal: J Neuroinflammation
Title: IL-33 deficiency causes persistent inflammation and severe neurodegeneration in retinal detachment.
Volume: 16
Issue: 1
Pages: 251
Publication
First Author: Oh JE
Year: 2016
Journal: Proc Natl Acad Sci U S A
Title: Dysbiosis-induced IL-33 contributes to impaired antiviral immunity in the genital mucosa.
Volume: 113
Issue: 6
Pages: E762-71
Publication
First Author: Nakanishi W
Year: 2013
Journal: PLoS One
Title: IL-33, but not IL-25, is crucial for the development of house dust mite antigen-induced allergic rhinitis.
Volume: 8
Issue: 10
Pages: e78099
Publication  
First Author: Augustine J
Year: 2023
Journal: Dis Model Mech
Title: IL-33 regulates Müller cell-mediated retinal inflammation and neurodegeneration in diabetic retinopathy.
Volume: 16
Issue: 9
Publication
First Author: Shimura S
Year: 2016
Journal: J Invest Dermatol
Title: Epicutaneous Allergic Sensitization by Cooperation between Allergen Protease Activity and Mechanical Skin Barrier Damage in Mice.
Volume: 136
Issue: 7
Pages: 1408-1417
Publication  
First Author: Toyama S
Year: 2021
Journal: Int J Mol Sci
Title: Regulatory T Cells Exhibit Interleukin-33-Dependent Migratory Behavior during Skin Barrier Disruption.
Volume: 22
Issue: 14
Publication
First Author: Xia Y
Year: 2019
Journal: Biochem Biophys Res Commun
Title: Endogenous IL-33 exerts CD8+ T cell antitumor responses overcoming pro-tumor effects by regulatory T cells in a colon carcinoma model.
Volume: 518
Issue: 2
Pages: 331-336
Publication
First Author: Shlomovitz I
Year: 2019
Journal: FEBS J
Title: Necroptosis directly induces the release of full-length biologically active IL-33 in vitro and in an inflammatory disease model.
Volume: 286
Issue: 3
Pages: 507-522
Publication
First Author: Xiang Y
Year: 2016
Journal: J Immunol
Title: MicroRNA-487b Is a Negative Regulator of Macrophage Activation by Targeting IL-33 Production.
Volume: 196
Issue: 8
Pages: 3421-8
Publication
First Author: Liang Y
Year: 2013
Journal: J Immunol
Title: IL-33 induces nuocytes and modulates liver injury in viral hepatitis.
Volume: 190
Issue: 11
Pages: 5666-75
Publication
First Author: Baekkevold ES
Year: 2003
Journal: Am J Pathol
Title: Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules.
Volume: 163
Issue: 1
Pages: 69-79
Publication
First Author: Pastorelli L
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis.
Volume: 107
Issue: 17
Pages: 8017-22
Publication
First Author: Hazlett LD
Year: 2010
Journal: Invest Ophthalmol Vis Sci
Title: IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis.
Volume: 51
Issue: 3
Pages: 1524-32
Publication
First Author: Matsuba-Kitamura S
Year: 2010
Journal: Int Immunol
Title: Contribution of IL-33 to induction and augmentation of experimental allergic conjunctivitis.
Volume: 22
Issue: 6
Pages: 479-89
Publication
First Author: Arshad MI
Year: 2011
Journal: Eur J Immunol
Title: NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis.
Volume: 41
Issue: 8
Pages: 2341-8
Publication
First Author: Keller J
Year: 2012
Journal: Biochem Biophys Res Commun
Title: Transgenic over-expression of interleukin-33 in osteoblasts results in decreased osteoclastogenesis.
Volume: 417
Issue: 1
Pages: 217-22
Publication
First Author: Rui T
Year: 2012
Journal: Cardiovasc Res
Title: Reduction in IL-33 expression exaggerates ischaemia/reperfusion-induced myocardial injury in mice with diabetes mellitus.
Volume: 94
Issue: 2
Pages: 370-8
Publication
First Author: Yin H
Year: 2013
Journal: Mol Immunol
Title: IL-33 accelerates cutaneous wound healing involved in upregulation of alternatively activated macrophages.
Volume: 56
Issue: 4
Pages: 347-53
Publication
First Author: Pollheimer J
Year: 2013
Journal: Arterioscler Thromb Vasc Biol
Title: Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells.
Volume: 33
Issue: 2
Pages: e47-55
Publication
First Author: Hashiguchi M
Year: 2015
Journal: Eur J Immunol
Title: IL-33 activates eosinophils of visceral adipose tissue both directly and via innate lymphoid cells.
Volume: 45
Issue: 3
Pages: 876-85
Publication  
First Author: Chen H
Year: 2015
Journal: Neuroscience
Title: Interleukin-33 is released in spinal cord and suppresses experimental autoimmune encephalomyelitis in mice.
Volume: 308
Pages: 157-68
Publication
First Author: Lima IL
Year: 2015
Journal: Am J Pathol
Title: Osteoprotective Effects of IL-33/ST2 Link to Osteoclast Apoptosis.
Volume: 185
Issue: 12
Pages: 3338-48
Publication
First Author: De Salvo C
Year: 2016
Journal: Am J Pathol
Title: IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis.
Volume: 186
Issue: 4
Pages: 885-98
Publication
First Author: Matta BM
Year: 2016
Journal: Blood
Title: Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD.
Volume: 128
Issue: 3
Pages: 427-39
Publication  
First Author: Bessa J
Year: 2014
Journal: J Autoimmun
Title: Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation.
Volume: 55
Pages: 33-41
Publication
First Author: Li C
Year: 2014
Journal: PLoS Pathog
Title: Interleukin-33 increases antibacterial defense by activation of inducible nitric oxide synthase in skin.
Volume: 10
Issue: 2
Pages: e1003918
Publication
First Author: Ndaw VS
Year: 2017
Journal: J Immunol
Title: TGF-β1 Suppresses IL-33-Induced Mast Cell Function.
Volume: 199
Issue: 3
Pages: 866-873
Publication
First Author: Islam MS
Year: 2016
Journal: Br J Pharmacol
Title: Epidermal growth factor is a critical regulator of the cytokine IL-33 in intestinal epithelial cells.
Volume: 173
Issue: 16
Pages: 2532-42
Publication
First Author: Xu L
Year: 2018
Journal: Eur J Immunol
Title: The IL-33-ST2-MyD88 axis promotes regulatory T cell proliferation in the murine liver.
Volume: 48
Issue: 8
Pages: 1302-1307
Publication
First Author: Hsu CL
Year: 2020
Journal: PLoS One
Title: Allergic inflammation is initiated by IL-33-dependent crosstalk between mast cells and basophils.
Volume: 15
Issue: 1
Pages: e0226701
Publication
First Author: Drake LY
Year: 2019
Journal: J Immunol
Title: Early Life Represents a Vulnerable Time Window for IL-33-Induced Peripheral Lung Pathology.
Volume: 203
Issue: 7
Pages: 1952-1960
Publication
First Author: Dos Santos JC
Year: 2017
Journal: Sci Rep
Title: Stingray venom activates IL-33 producing cardiomyocytes, but not mast cell, to promote acute neutrophil-mediated injury.
Volume: 7
Issue: 1
Pages: 7912
Publication  
First Author: Xiao W
Year: 2019
Journal: J Neuroimmunol
Title: The role of Interleukin-33 in the modulation of splenic T-cell immune responses after experimental ischemic stroke.
Volume: 333
Pages: 576970
Publication
First Author: Allinne J
Year: 2019
Journal: J Allergy Clin Immunol
Title: IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation.
Volume: 144
Issue: 6
Pages: 1624-1637.e10
Publication  
First Author: Rood JE
Year: 2018
Journal: Front Immunol
Title: Disruption of IL-33 Signaling Limits Early CD8+ T Cell Effector Function Leading to Exhaustion in Murine Hemophagocytic Lymphohistiocytosis.
Volume: 9
Pages: 2642
Publication  
First Author: Swann JW
Year: 2020
Journal: J Exp Med
Title: IL-33 promotes anemia during chronic inflammation by inhibiting differentiation of erythroid progenitors.
Volume: 217
Issue: 9
Publication
First Author: Chen Z
Year: 2020
Journal: Immunology
Title: Interleukin-33 alleviates psoriatic inflammation by suppressing the T helper type 17 immune response.
Volume: 160
Issue: 4
Pages: 382-392
Publication
First Author: Piyadasa H
Year: 2020
Journal: Biochim Biophys Acta Mol Basis Dis
Title: Characterization of immune responses and the lung transcriptome in a murine model of IL-33 challenge.
Volume: 1866
Issue: 12
Pages: 165950
Publication
First Author: Cao S
Year: 2020
Journal: Biochem Biophys Res Commun
Title: Helicobacter hepaticus infection-induced IL-33 promotes hepatic inflammation and fibrosis through ST2 signaling pathways in BALB/c mice.
Volume: 525
Issue: 3
Pages: 654-661